REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA

The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BIETH, Bruno, JUHNKE, Michael, GRAHAM, Gordon, ZIERER, Jonas Benjamin, LOESCHE, Christian, CENNI, Bruno, RAPP, Karin, SIN, Kim-Hien, BHATTACHARYA, Souvik
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinations, dosage forms, and kits for use in the disclosed uses and methods. La présente invention concerne des méthodes de traitement et/ou de prévention de l'hidradénite suppurée chez un sujet atteint d'une telle maladie ou affection, comprenant l'administration d'une dose thérapeutiquement efficace de LOU064. L'invention concerne également des médicaments, des schémas posologiques, des compositions pharmaceutiques, des combinaisons, des formes posologiques et des kits destinés à être employés dans les utilisations et les procédés de l'invention.